There was widespread consensus that drug regulators and patient groups need to work more closely together in Latin America at a multi-stakeholder seminar held in Rio de Janeiro, Brazil yesterday.
IAPO members in Chile have been involved in the introduction of a new law to cover the treatment of high cost diseases.